Drugs Medical Pharma

Novartis AG to buy experimental oral drug of Pikavation for $3 billion

Novartis AG has agreed to buy an investigational oral medicine of Pikavation Therapeutics, a subsidiary of privately-held Synnovation Therapeutics, to treat breast cancer, for.

Read More